Advertisement
Document › Details
Agilent Technologies Inc.. (3/2/17). "Press Release: Agilent Technologies Introduces Postnatal Assay for Detection of Genetic Anomalies. GenetiSure Dx Postnatal Assay Can Help Move Inquiries from Cause to Care Faster". Santa Clara, CA.
Region | EU (European Union) | |
Organisation | Agilent Technologies Inc. (NYSE: A) | |
Product | GenetiSure Dx Postnatal CGH Assay | |
Person | Verrelst, Herman (Biocartis 202304– Board Chair before CEO before Agilent + Cartagenia + Medicim + Data4s) | |
Person 2 | Wadsworth-Hansen, Victoria (Agilent 201506 Director Global Business Public Relations) | |
Agilent Technologies Inc. (NYSE: A) has introduced its first comparative genomic hybridization (CGH) assay for diagnostic use: the GenetiSure Dx Postnatal Assay. This assay will enable clinical geneticists to detect genetic anomalies earlier and more accurately than traditional methods can.
Such anomalies have been associated with developmental delay, intellectual disability, autism, congenital irregularities and dysmorphic features in children and adults.
The GenetiSure Dx Postnatal Assay is the result of an extensive clinical validation and brings CGH technology into diagnostics. This assay is based on Agilent's proprietary array for comparative genomic hybridization providing data on copy number variations and absence of heterozygosity, and will carry CE Marking for in vitro diagnostics.
By helping to identify a definitive genetic diagnosis, the assay can rapidly change the focus of a medical investigation from finding the cause to administering appropriate medical care and family support.
"The GenetiSure Dx Postnatal Assay has been developed for cytogenetic laboratories, combining high-quality data with easy laboratory setup and streamlined protocols," said Herman Verrelst, Agilent vice president and general manager of the company's Genomics Solutions Division and Clinical Applications Division. "From DNA to data analysis, this assay allows for easy implementation into the clinical routine."
Verrelst noted that GenetiSure Dx is a validated solution that will help clinical labs implement important cytogenetic testing.
About Agilent Technologies
Agilent Technologies Inc. (NYSE: A), a global leader in life sciences, diagnostics and applied chemical markets, is the premier laboratory partner for a better world. Agilent works with customers in more than 100 countries, providing instruments, software, services and consumables for the entire laboratory workflow. The company generated revenues of $4.20 billion in fiscal 2016 and employs about 12,500 people worldwide. Information about Agilent is available at www.agilent.com.
# # #
Contact:
Victoria Wadsworth-Hansen
Agilent Technologies
+1 408-553-2005
+45 29336980
victoria.wadsworth-hansen@agilent.com
Record changed: 2023-06-05 |
Advertisement
More documents for Agilent (Group)
- [1] Agilent Technologies Inc.. (2/21/24). "Press Release: Agilent CEO Mike McMullen to Retire Agilent CrossLab Group – President Padraig McDonnell Named CEO-Elect". Santa Clara, CA....
- [2] Agilent Technologies Inc.. (12/20/23). "Press Release: Agilent Makes Strategic Updates to Organizational Structure". Santa Clara, CA....
- [3] Agilent Technologies Inc.. (12/18/23). "Press Release: Agilent to Present at the 42nd Annual J.P. Morgan Healthcare Conference". Santa Clara, CA....
- [4] Agilent Technologies Inc.. (9/12/23). "Press Release: Agilent Technologies and Exact Sciences Agree to Terms of Sale for Resolution Bioscience". Santa Clara, CA & Madison, WI....
- [5] Illumina, Inc.. (9/5/23). "Press Release: Illumina's Board Appoints Jacob Thaysen, Ph.D. as its New Chief Executive Officer". San Diego, CA....
- [6] Agilent Technologies Inc.. (9/5/23). "Press Release: Agilent Names Philip Binns to Lead Life Sciences and Applied Markets Group". Santa Clara, CA....
- [7] Agilent Technologies Inc.. (9/4/23). "Press Release: Agilent and ACTRIS Partner to Accelerate Cell and Gene Therapy in Singapore". Singapore....
- [8] Agilent Technologies Inc.. (8/3/23). "Press Release: Agilent Announces Thought Leader Award to Peter Neubauer". Santa Clara, CA....
- [9] Agilent Technologies Inc.. (6/12/23). "Press Release: Agilent Introduces New Comprehensive GPC/SEC Solutions at HPLC 2023 Conference". Santa Clara, CA....
- [10] Synthego Corporation. (5/17/23). "Press Release: Synthego Announces Invalidation of Agilent Patents in CRISPR Dispute". Redwood City, CA....
To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com
Advertisement
» top